Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen-Reference-Cited by-同舟云学术

Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen

Published:2005-09-15 Issue:18 Volume:11 Page:6414-6421
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Johnson John R.,Cohen Martin,Sridhara Rajeshwari,Chen Yeh-Fong,Williams Gene M.,Duan John,Gobburu Jogarao,Booth Brian,Benson Kimberly,Leighton John,Hsieh Li Shan,Chidambaram Nallalerumal,Zimmerman Paul,Pazdur Richard

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of diphenyl ether substituted quinazolin-4-amine derivatives as potent EGFRL858R/T790M/C797S inhibitors;European Journal of Medicinal Chemistry;2024-12

2. Bulk RNA analysis identified the characteristics and immunoinvasive patterns of osimertinib resistance in patients with non-small cell lung cancer;2024-09-11

3. Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials;Medical Oncology;2024-06-12

4. Formation and characterization of charge transfer complex between alectinib and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone: Application to development of microwell spectrophotometric method;Sustainable Chemistry and Pharmacy;2024-06

5. Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists;iScience;2024-02